metformin aurobindo 500 mg film-coated tablets
aurobindo pharma (malta) limited - metformin hydrochloride - film-coated tablet - 500 milligram(s) - biguanides; metformin
metformin aurobindo 850 mg film-coated tablets
aurobindo pharma (malta) limited - metformin hydrochloride - film-coated tablet - 850 milligram(s) - biguanides; metformin
metformin aurobindo 1000 mg film-coated tablets
aurobindo pharma (malta) limited - metformin hydrochloride - film-coated tablet - 1000 milligram(s) - biguanides; metformin
metformin teva 500 mg film-coated tablets
teva pharma b.v. - metformin hydrochloride - film-coated tablet - 500 milligram(s) - biguanides; metformin
metformin teva 850 mg film-coated tablets
teva pharma b.v. - metformin hydrochloride - film-coated tablet - 850 milligram(s) - biguanides; metformin
metformin teva 1000 mg film-coated tablets
teva pharma b.v. - metformin hydrochloride - film-coated tablet - 1000 milligram(s) - biguanides; metformin
metformin bluefish 850 mg, film-coated tablets
bluefish pharmaceuticals ab - metformin hydrochloride - film-coated tablet - 850 milligram(s) - biguanides; metformin
metformin bluefish 1000 mg, film-coated tablets
bluefish pharmaceuticals ab - metformin hydrochloride - film-coated tablet - 1000 milligram(s) - biguanides; metformin
metformin bluefish 500 mg, film-coated tablets
bluefish pharmaceuticals ab - metformin hydrochloride - film-coated tablet - 500 milligram(s) - biguanides; metformin
nesina met 12.5/1000; 12.5 mg alogliptin (as benzoate) / 1000 mg metformin hydrochloride film-coated tablets blister pack
takeda pharmaceuticals australia pty ltd - metformin hydrochloride, quantity: 1000 mg; alogliptin benzoate, quantity: 17 mg (equivalent: alogliptin, qty 12.5 mg) - tablet, film coated - excipient ingredients: povidone; microcrystalline cellulose; hypromellose; crospovidone; mannitol; purified talc; titanium dioxide; iron oxide yellow; magnesium stearate - nesina met is indicated to improve glycaemic control in adult patients (> or = 18 years old) with type 2 diabetes mellitus when diet and exercise do not provide adequate glycaemic control and treatment with both alogliptin and metformin is appropriate,,- when treatment with metformin alone does not provide adequate control; or - in combination with a thiazolidinedione or with insulin, when dual therapy does not provide adequate control.,nesina met can also be used to replace separate tablets of alogliptin and metformin in patients already being treated with this combination.